抑制ACE2-S蛋白相互作用的短功能与一个弹结构的功能
Yuping Wei1,2,3, Ziyang Liu1,2, Man Zhang2,4
1School of Life Science, Nanyang Normal University, Nanyang 473061, China.
Molecules (Basel, Switzerland)
|July 13, 2024
概括
一种新,KYPAY (K5),通过阻断尖端蛋白质,有效地抑制SARS-CoV-2的进入.
科学领域:
- 病毒学和药理学.
- 药物发现和开发 药物发现和开发
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 由于其快速演变和致病性,构成了全球健康的重大威胁.
- SARS-CoV-2 尖端蛋白 (S 蛋白) 使用人类血管素转化酶-2 (ACE2) 作为病毒进入的主要细胞受体.
- 针对ACE2-S蛋白相互作用是开发抗病毒疗法的关键策略.
研究的目的:
- 开发和评估一种新的功能性,KYPAY (K5),作为对抗SARS-CoV-2的药理学对抗剂.
- 调查K5在SARS-CoV-2 S蛋白和人类ACE2之间的相互作用上的抑制潜力.
- 评估K5在预防病毒进入方面的安全性和有效性.
主要方法:
- 使用分子模拟,包括雨采样 (美国),以评估K5与ACE2和细胞膜的结合亲和力.
- 进行了基于细胞的实验,包括光显微镜和细胞毒性测定,以评估K5的抑制作用和细胞安全性.
- 使用流细胞计量来量化K5.5对ACE2-S蛋白相互作用的抑制.
主要成果:
- 分子模拟表明,K5对ACE2具有很高的亲和力,对细胞膜的亲和力较低.
- 美国的模拟证实了K5对ACE2的结合潜力的显著增强.
- 细胞实验表明,K5有效地阻止了ACE2-S蛋白相互作用而不会诱导细胞毒性,在100μM度达到78%的抑制.
结论:
- 功能性KYPAY (K5) 是SARS-CoV-2 S蛋白-ACE2相互作用的强有力的抑制剂.
- K5表现出良好的安全性,没有明显伤害细胞.
- 这项研究将K5作为开发针对SARS-CoV-2感染的新型治疗策略的有希望的候选人.
更多相关视频
08:09Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.5K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.0K
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
600
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
600
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
695
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
695
01:25Antihypertensive Drugs: Direct Renin Inhibitors
546
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
546
01:28Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697